Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Gisela Backfisch"'
Autor:
Marjoleen Nijsen, Katja Jantos, Helmut Mack, Wilfried Hornberger, Achim Moeller, Andreas Kling, Gisela Backfisch, Yanbin Lao, Beatrice Rendenbach-Mueller
Publikováno v:
ACS Medicinal Chemistry Letters. 9:221-226
[Image: see text] Dysregulation of calpains 1 and 2 has been implicated in a variety of pathological disorders including ischemia/reperfusion injuries, kidney diseases, cataract formation, and neurodegenerative diseases such as Alzheimer’s disease
Publikováno v:
Chemistry – A European Journal. 24
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany). 24(68)
Late-stage functionalization of lead compounds is of high interest in drug discovery since it offers an easy access to metabolites and derivatives of a lead compound without the need to redesign an often long multistep synthesis. Owing to their high
Publikováno v:
Arzneimittelforschung. 50:664-668
Two compounds, an aminobisphosphonate (A) and a steroid (B), showing a very large difference in lipophilicity (log PC (A) = O, log PC (B) > 8) but both revealing very poorly absorption in vivo of less than 1% were tested in respect of in vitro absorp
Autor:
W. Lubisch, Astrid Netz, Wilfried Hornberger, Swati Bhowmik, Liliane Unger, Hervé Geneste, Wolfgang Wernet, Marcel M. van Gaalen, Thorsten Oost, Gisela Backfisch
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:3828-3831
Herein we report the discovery of a novel series of vasopressin 1b (V1b) receptor antagonists, starting from potent but metabolically labile oxindole SSR149415. Masking the proline N,N-dimethyl amide moiety as an oxazole and attaching a benzylic amin
Autor:
Norbert Zimmermann, Jürgen Delzer, Andreas Kling, Gisela Backfisch, Thomas Subkowski, Hervé Geneste, Wilfried Hornberger, Claudia Isabella Graef, Werner Seitz
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:527-531
An unexpected ring contraction of benzazepinone based α v β 3 antagonists led to the design of quinolinone-type derivatives. Novel and efficient synthetic routes to isoquinolinone, benzoxazinone, and quinazolinone acetates were established. Nanomol
Autor:
Andreas Haupt, Liliane Unger, Linda L. King, W. Lubisch, Gisela Backfisch, Hervé Geneste, Hans-Jürgen Teschendorf, Jürgen Delzer, Gerd Steiner, Charles W. Hutchins, Wilfried Braje, Wolfgang Wernet
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 16:658-662
The synthesis and SAR of novel and selective dopamine D(3)-receptor antagonists based on a 3,4-dihydro-1H-quinolin-2-one, a 1,3,4,5-tetrahydro-benzo[b]azepin-2-one, 1H-quinoline-2,4-dione or a 3,4-dihydro-1H-benzo[b]azepine-2,5-dione scaffold are dis
Autor:
Andreas Haupt, Jürgen Delzer, Hervé Geneste, Hans-Jürgen Teschendorf, Wilfried Braje, Andreas Kling, Liliane Unger, Wolfgang Wernet, Charles W. Hutchins, Linda L. King, Gisela Backfisch
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 16:490-494
The synthesis and SAR of novel highly potent and selective dopamine D(3)-receptor antagonists based on a 1H-pyrimidin-2-one scaffold are described. A-690344 antagonized PD 128907-induced huddling deficits in rat (ED(50) 6.1mg/kg po), a social interac
Autor:
Michael Schulz, Juliane Hoeckels-Messemer, Jonas Angstenberger, Beate Reder-Hilz, Gisela Backfisch, Jens Sydor, Loic Laplanche
Publikováno v:
Bioanalysis. 7(6)
Background: Metabolite identification studies are very resource intensive and also are rarely performed in early discovery. Here, we report the validation of an ultraperformance liquid chromatography–high-resolution mass spectrometry (UPLC-HRMS) pl
Autor:
Jürgen Delzer, Wilfried Hornberger, Christian Zechel, Gisela Backfisch, Thomas Subkowski, Andreas Kling, Werner Seitz, Claudia Isabella Graef, Udo E.W Lange, Hervé Geneste, Arnulf Lauterbach
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:165-169
Solid-phase synthesis and SAR of alpha(V)beta(3)-receptor antagonists based on a N(1)-substituted 4-amino-1H-pyrimidin-2-one scaffold are described. The most potent compounds exhibited IC(50) values towards alpha(V)beta(3) in the nano- to subnanomola